Table3.
Demographic data of patients who underwent a second PSG to assess the efficacy of OA use
| All | Severity | Psychiatric Disorder | ||||
|---|---|---|---|---|---|---|
| Mild | Moderate | + | − | |||
| N | 74 | 50 | 24 | 29 | 45 | |
| Sex, Male（%） | 66 (89.2) | 45 (90.0) | 21 (87.5) | 26 (89.7) | 40 (88.9) | |
| Age (years) | 41.9±12.1 | 40.7±10.0 | 44.4±15.6 | 41.9±10.3 | 41.9±13.3 | |
| BMI | 26.2±4.7 | 25.7±4.5 | 27.6±5.0 | 26.8±5.7 | 25.9±4.1 | |
| Psychiatric Disorder, + (%) | 29 (39.2) | 21 (42.0) | 8 (33.3) | — | — | |
| PSGs Interval (days) | 280.5±199.4 | 291.6±203.8 | 223.8±93.2 | 283.0±151.6 | 261.0±194.0 | |
| ESS# | ||||||
| before OA | 11.1±4.8 | 11.3±4.6 | 10.7±5.3 | 9.8±4.7 | 12.0±4.7 | |
| after OA | 8.9±4.9 | 8.8±4.8 | 9.1±5.3 | 7.7±4.7 | 9.7±5.0 | |
| AHI (/hr) | ||||||
| before OA | 12.5±5.0 | 9.6±2.5 | 18.7±2.3 | 12.6±5.1 | 12.5±4.9 | |
| after OA | 6.6±5.8 | 4.9±4.2 | 10.1±7.1 | 7.3±6.4 | 6.1±5.4 | |
Values are presented as means±standard deviations. There were missing data for the ESS# (n=1 patient), and the corresponding patient was excluded from both of before and after OA use for calculation.
PSG, polysomnography; ESS, Epworth Sleepiness Scale; OA, oral appliance